CVS Health Corporation

Historical 13F Holders

Symbol
CVS
CUSIP
126650100
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 126650100 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 8.3% 7/16/2025
Event 6/30/2025
Vanguard Capital Management LLC 13G 7.5% 4/29/2026
Event 3/31/2026
Capital World Investors 13G 5.5% 5/13/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Dodge & Cox 13G/A 3.9% 8/13/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1,998 1.11 B $95.0B
2026 Q2 2,102 1.14 B $119B
2026 Q1 1,902 1.11 B $79.4B
2025 Q4 1,971 1.13 B $89.9B
2025 Q3 1,856 1.11 B $84.0B
2025 Q2 1,780 1.10 B $75.6B
2025 Q1 1,783 1.08 B $73.4B
2024 Q4 1,690 1.05 B $47.1B
2024 Q3 1,863 1.02 B $64.3B
2024 Q2 1,931 1.03 B $60.6B
2024 Q1 2,202 1.01 B $80.1B
2023 Q4 2,283 1.02 B $80.5B
2023 Q3 2,134 1.00 B $70.4B
2023 Q2 2,221 999 M $69.0B
2023 Q1 2,287 1.02 B $74.5B
2022 Q4 2,424 1.03 B $107B
2022 Q3 2,339 1.04 B $99.6B
2022 Q2 2,323 1.03 B $96.2B
2022 Q1 2,380 1.03 B $105B
2021 Q4 2,360 1.03 B $107B
2021 Q3 2,091 1.02 B $87.2B
2021 Q2 2,082 1.02 B $86.0B
2021 Q1 2,044 997 M $75.6B
2020 Q4 1,989 997 M $68.9B
2020 Q3 1,826 998 M $58.7B
2020 Q2 1,877 1.02 B $66.5B
2020 Q1 1,825 1.01 B $60.1B
2019 Q4 1,856 1.02 B $75.5B
2019 Q3 1,702 1.01 B $64.1B
2019 Q2 1,668 1.01 B $55.0B
2019 Q1 1,722 1.02 B $55.1B
2018 Q4 1,786 1.06 B $69.7B
2018 Q3 1,625 879 M $69.2B
2018 Q2 1,591 861 M $55.4B
2018 Q1 1,564 858 M $53.4B
2017 Q4 1,612 855 M $61.9B
2017 Q3 1,546 840 M $68.3B
2017 Q2 1,561 841 M $67.7B
2017 Q1 1,593 848 M $66.6B
2016 Q4 1,556 870 M $68.7B
2016 Q3 1,567 878 M $78.3B
2016 Q2 1,577 875 M $87.5B
2016 Q1 1,572 926 M $93.4B
2015 Q4 1,561 923 M $90.7B
2015 Q3 1,512 932 M $89.9B
2015 Q2 1,489 935 M $98.0B
2015 Q1 1,463 941 M $97.2B
2014 Q4 1,424 961 M $93.0B
2014 Q3 1,292 970 M $77.2B
2014 Q2 1,270 970 M $74.5B
2014 Q1 1,242 995 M $74.9B